Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
DART Ventures is a venture capital firm founded to support early-stage Swiss and European teams developing breakthrough technologies that address health and climate challenges. Established in Zurich, Switzerland, the firm also operates an office in San Francisco, California, facilitating connections between European startups and the U.S. market. This dual presence allows DART Ventures to provide comprehensive guidance on strategy, culture, fundraising, and expansion.
The firm has built a diverse portfolio of 14 companies, focusing on impactful innovations that merge health and climate solutions. DART Ventures emphasizes the importance of purpose-driven investments, aiming to create a positive impact while generating financial returns. Their commitment to supporting early-stage startups positions them as a key player in the venture capital landscape.
DART Ventures invests in early-stage startups that focus on health and climate solutions. Their investment strategy encompasses several sectors, including health tech, consumer health, and climate technology. The firm targets companies at various stages, including pre-seed, seed, seed-plus, and Series A, with check sizes that align with these early stages.
The investment thesis of DART Ventures emphasizes the integration of purpose and profit, particularly in developing AI-enabled healthcare tools and decarbonization technologies. They seek startups that not only aim for financial success but also strive to create impactful solutions that address pressing health and climate challenges. This focus on meaningful innovation positions DART Ventures as a valuable partner for founders in these sectors.
DART Ventures has a diverse portfolio that includes notable companies across various sectors. Key portfolio companies include:
This portfolio reflects DART Ventures' commitment to supporting innovative solutions that address critical health and climate issues.
Sophie Lamparter - Managing Partner: Sophie has extensive experience in venture capital and has led numerous successful investments in health and climate sectors. She holds a degree in Business Administration from a top Swiss university.
Arijana Walcott - Managing Partner: Arijana specializes in early-stage investments and has a strong background in technology and innovation. She has previously worked with several notable startups in Europe.
Doug Griffin - Venture Partner US: Doug brings a wealth of experience from his time in Silicon Valley, where he has been involved in various successful tech ventures. He holds an MBA from a prestigious institution.
Priska Roesli - Venture Partner: Priska has a background in healthcare and has worked with multiple startups focused on health tech solutions. She is known for her strategic insights and operational expertise.
Walter Greenleaf - Venture Partner US: Walter has a strong track record in the biotech sector and has been instrumental in guiding startups through their growth phases. He has a PhD in Neuroscience.
Aimée Leifer - Venture Partner US: Aimée specializes in consumer health and has a background in product development and marketing. She has worked with several successful health-focused startups.
To pitch DART Ventures, founders should send an email to hello@dart.ventures. A well-structured pitch deck is essential, including information about the startup's mission, market opportunity, team, and financial projections. Founders should expect a response within a few weeks, depending on the volume of inquiries.
Warm introductions are preferred, but cold emails are also accepted. It is crucial to make a strong first impression, as DART Ventures receives numerous pitches and seeks startups that align with their investment thesis.
In recent months, DART Ventures has actively supported its portfolio companies, helping them navigate growth challenges and expand into new markets. The firm has been involved in strategic discussions with several startups to enhance their fundraising efforts.
Additionally, DART Ventures has been expanding its presence in both Europe and the U.S., strengthening its operational capabilities and enhancing its support for portfolio companies. This expansion reflects the firm's commitment to connecting European startups with the U.S. market.
What are DART Ventures' investment criteria?
DART Ventures focuses on early-stage startups in health and climate sectors, particularly those developing impactful solutions that combine purpose and profit. They invest in companies at pre-seed, seed, seed-plus, and Series A stages.
How can I pitch to DART Ventures?
Founders can reach out via email at hello@dart.ventures. A well-prepared pitch deck should include details about the startup's mission, market opportunity, team, and financial projections.
What makes DART Ventures different from other investors?
DART Ventures emphasizes transatlantic connections, providing European startups with access to the U.S. market. Their focus on health and climate solutions, combined with a commitment to purpose-driven investments, sets them apart.
What is the geographic scope of DART Ventures?
The firm primarily invests in startups based in Switzerland and Europe, while also facilitating connections with the U.S. market through their San Francisco office.
What kind of support do portfolio companies receive?
DART Ventures provides guidance on strategy, culture, fundraising, and expansion to help startups navigate their growth. They actively support their portfolio companies in achieving their goals.
What is the typical check size for investments?
While specific check sizes are not disclosed, DART Ventures invests in early-stage companies, which typically involves smaller amounts compared to later-stage investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.